Psychedelics Colorado students interested in psychedelics gain access to US$1.5M grant Those enrolling at Naropa University who want to do a minor in psychedelics now have more incentive Rowan DunneMarch 4, 2025
Cannabis Weedmaps parent company stock spikes after proposition to go private The multi-purpose cannabis platform operator has been on a steady decline since it went public in 2021 Rowan DunneDecember 18, 2024
Psychedelics MAPS partners with diverse artist lineup for psychedelic music & education initiative The 'Music is the Bridge' campaign has created an assortment of playlists specifically made for psychedelic trips Rowan DunneDecember 9, 2024
Cannabis FDA gives long-awaited green light to veterans cannabis trial for PTSD After 3 years of negotiating, a cannabis smoking study with 320 American vets is about to kick off Rowan DunneNovember 20, 2024
Psychedelics Investors wince as FDA panel rejects proposal to approve ‘molly’ for PTSD therapy Despite rejection from the advisory committee, the FDA won't make its final decision on the matter until August Rowan DunneJune 5, 2024
Psychedelics MAPS subsidiary raises over US$100M to support MDMA regulation The funding was led by the non-profit Helena, a diverse organization that aims to solve global problems Rowan DunneJanuary 5, 2024
Psychedelics Billionaire Steve Cohen’s Point 72 hedge fund takes 8.1% stake in Cybin It now has 19 million shares of the psychedelic drug developer, the firm's first investment in a public entity of this variety Rowan DunneSeptember 19, 2023
News MDMA-assisted therapy significantly reduces moderate to severe PTSD symptoms The study findings represent the culmination of more than two decades of dedicated research efforts Natalia Buendia CalvilloSeptember 15, 2023
Psychedelics Optimi Health to supply MDMA for new psychedelic therapy program at Numinus clinics The experiential training will only be available through Numinus and will utilize the protocol of MAPS Rowan DunneJune 15, 2023
Psychedelics Psycheceutical Bioscience develops non-psychoactive ketamine topical for PTSD and depression NeuroDirect Ketamine can also help alleviate headaches and migraines within minutes, with no trip involved Rowan DunneJune 14, 2023